ZVRA
Zevra Therapeutics, Inc.Company with tickers: ZVRA
CIK
1434647
CUSIP
488445206
Shares Outstanding
59,115,084
Website
https://www.zevra.com
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$50,000,000
as of 2021-12-20
· not restated in filings since 2024-11-13
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2024-12-31 | $0 | 10-K, filed 2025-03-12 |
| 2023-12-31 | $3,447,000 | 10-K, filed 2025-03-12 |
| 2022-12-31 | $4,723,000 | 10-K, filed 2024-04-01 |
| 2021-12-31 | $2,814,000 | 10-K, filed 2022-03-31 |
| 2020-12-31 | $0 | 10-K, filed 2022-03-31 |